Stroke risk reduction from thrombin inhibitor in AFib patients
A recently approved direct thrombin inhibitor was found to reduce the risk of stroke/peripheral embolic events in atrial fibrillation patients by 34%, and the risk of hemorrhagic stroke by 74%—compared… [ Get More Details ]
Treatment for hypertension using antihypertensive therapy has generated a benefit-to-cost ratio of at least 6:1.
[ Get More Details ]
Antihypertensive therapy has had a major impact on health. Without it, 1999-2000 average blood pressures (at age 40 or over) would have been 10-13% higher, and 86,000 more premature deaths… [ Get More Details ]
The use of ACE inhibitors in hypertensive patients 80 years of older was associated in this study with a 30% reduction in the rate of stroke and a 64% reduction… [ Get More Details ]
Full medication coverage is expected to increase patient compliance from 50% to 76%. Expanded coverage would cost insurers an average of $644 more per patient, but would avert an average… [ Get More Details ]